Funding

Faro AI

United States · Healthtech

Structured data and AI agents for clinical development and pharmaceutical trial operations.

Visit faro.aiFunding history

Product

Faro AI develops structured data infrastructure and AI agents for clinical drug development. Pharmaceutical teams use its platform to organize clinical-trial information and automate development work.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$37.3MS32 — LeadAnkona Capital — ParticipantGeneral Catalyst — ParticipantPolaris Partners — Participant

Investors

S32Led Series BAnkona CapitalJoined Series BGeneral CatalystJoined Series BPolaris PartnersJoined Series B

Coverage

Aug 30, 2026Faro AI · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
CureBayCureBay operates a hybrid healthcare network for rural and underserved communities in India.~₹1B · Pre-Series C
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesaibusinessweekly.net ↗